Research and Development Expenses. Research and development expenses for the nine months ended September 30, 2014 were $366,275, a decrease of $408,535, or 52.7%, from $774,810 for the nine months ended September 30, 2013. This decrease is primarily due to reduction in personnel and consulting expenses due to funding constraints.
(0)
(0)
BioSig Technologies Inc. (BSGM) Stock Research Links